hydroxyurea has been researched along with Mucositis in 4 studies
Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperleukocytosis occurs in 15-20% of all newly diagnosed acute myeloid leukemia patients and requires emergent treatment with leukapheresis or hydroxyurea when accompanied by signs or symptoms of leukostasis." | 7.91 | Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia. ( Auten, JJ; Clark, SM; Trepte, ML; van Deventer, HW, 2019) |
| "Hydroxyurea (HU) resistance or intolerance occurs in 15 to 24% of patients with polycythemia vera (PV)." | 7.91 | Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis. ( Delforge, M; Demuynck, T; Devos, T; Vandenberghe, P; Verhoef, G, 2019) |
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 7.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Hyperleukocytosis occurs in 15-20% of all newly diagnosed acute myeloid leukemia patients and requires emergent treatment with leukapheresis or hydroxyurea when accompanied by signs or symptoms of leukostasis." | 3.91 | Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia. ( Auten, JJ; Clark, SM; Trepte, ML; van Deventer, HW, 2019) |
| "Hydroxyurea (HU) resistance or intolerance occurs in 15 to 24% of patients with polycythemia vera (PV)." | 3.91 | Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis. ( Delforge, M; Demuynck, T; Devos, T; Vandenberghe, P; Verhoef, G, 2019) |
| "To analyze the results of idarubicin (IDA)- versus etoposide (VP16)-intensified myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation (allo-SCT) for high-risk acute leukemia." | 3.75 | A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia. ( Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P, 2009) |
| "Mucositis was the main adverse effect of treatment." | 1.34 | Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient. ( Arndt, CA; Jensen, AW; Tefferi, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trepte, ML | 1 |
| Auten, JJ | 1 |
| Clark, SM | 1 |
| van Deventer, HW | 1 |
| Demuynck, T | 1 |
| Verhoef, G | 1 |
| Delforge, M | 1 |
| Vandenberghe, P | 1 |
| Devos, T | 1 |
| Li, QB | 1 |
| Li, L | 1 |
| You, Y | 1 |
| Chen, ZC | 1 |
| Xia, LH | 1 |
| Zou, P | 1 |
| Jensen, AW | 1 |
| Tefferi, A | 1 |
| Arndt, CA | 1 |
4 other studies available for hydroxyurea and Mucositis
| Article | Year |
|---|---|
Dose-related mucositis with hydroxyurea for cytoreduction in acute myeloid leukemia.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leuk | 2019 |
Polycythemia vera and hydroxyurea resistance/intolerance: a monocentric retrospective analysis.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance; Female; Fever; Follow-Up Studies; Humans; Hydroxyur | 2019 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combine | 2009 |
Cerebral venous sinus thrombosis associated with essential thrombocytosis in a pediatric patient.
Topics: Adolescent; Anticoagulants; Aspirin; Bone Marrow; Follow-Up Studies; Humans; Hydroxyurea; Magnetic R | 2007 |